Biocoat’s UV hydrophilic coating is reported to score high in lubricity and durability, among other criteria

July 26, 2022

HORSHAM, Pa.—An ultraviolet (UV) cure, hydrophilic coating from Biocoat, Inc., has been approved for a patent by the United States Patent and Trademark Office (USPTO), the company said in a release.

Biocoat is a specialty manufacturer of hydrophilic biomaterial coatings and a provider of contract coating services for medical devices. Its HYDAK® UV coating is “built on a bi-laminar platform,” according to Bob Hergenrother, Ph.D., Biocoat’s vice president of research, development, and innovation.

“Biocoat’s HYDAK® UV coating is built on a bi-laminar platform that offers industry-leading results in lubricity, durability, and particulates, which are the main criteria for measuring hydrophilic coating performance,” Hergenrother said in the release. “The acceptance of our USPTO filing confirms that our unique and proprietary technology is unmatched in the marketplace.”

Biocoat specializes in supplying lubricious, hydrophilic coatings that are custom-engineered to meet specific clinical parameters for medical devices. The company supplies these coatings to OEMs, start-up companies, and contract manufacturers. Biocoat also provides custom coating services, as well as dip-coating equipment, to medical device companies that require assistance with manufacturing, the company said.

The company provides high-performance hydrophilic coatings that use UV and thermal heat curing systems. Ultraviolet cure coatings are used on numerous medical devices that require a hydrophilic coating, particularly in the cardiovascular market. Thermal curing is often used on interventional medical devices that require extremely high-performance results. It may also be used for coating the inner diameter of substrate materials or on delivery cartridges that are used to place intraocular lenses (IOLs), Biocoat said in the release.

Biocoat President and CEO Jim Moran said the company introduced its HYDAK UV to the market in early 2020 and, since then, has fielded significant interest from current and new customers.

“The entire Biocoat team has worked tirelessly to support this new product launch, and we are proud to be recognized by this patent for our innovation,” Moran said in the release. “Our team is laser focused on ensuring that we offer customers the best hydrophilic coatings and product development support available in the industry today.”

Biocoat Board Chair Scott Cramer added, “The Biocoat team continues to innovate, which has pushed the organization to be recognized as the leading full-service hydrophilic coating company in the medical device industry.”

Subscribe Now

Design-2-Part Magazine

Get the manufacturing industry news and features you need for free in a format you like.

FREE Print, Digital, or Both »

You have Successfully Subscribed!